Navigation Links
M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
Date:3/10/2009

M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company has expanded its electronic image collection and transfer offering with access to AG Mednet, the global HIPAA and 21 CFR Part 11 compliant image exchange network. This enables M2S to offer clinical trial sponsors the ability to choose the optimal image collection and transfer method based on the needs of their particular trial.

(PRWEB) March 10, 2009 -- M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, announced today that the company has expanded its electronic image collection and transfer offering with access to AG Mednet, the global HIPAA and 21 CFR Part 11 compliant image exchange network. This enables M2S to offer clinical trial sponsors the ability to choose the optimal image collection and transfer method based on the needs of their particular trial.

Clinical trials are increasingly using medical imaging for inclusion criteria, secondary and surrogate endpoints and to serve as adjunctive safety assessment of drugs under development. Clinical trial imaging provides a non-invasive method of obtaining information on a drug's effects in the body and can provide crucial information for making early "go/no-go" decisions, potentially saving millions of dollars in development costs. Collecting and managing large amounts of imaging data securely and rapidly can be challenging and often costly for trial sponsors, and the traditional method of image transfer via hard media and courier services is very time-intensive and error prone. Electronic data transfer of images drastically reduces the time involved, provides the opportunity for early discovery and resolution of queries, and therefore can provide significant cost savings in clinical trials.

"We felt that an agreement with AG Mednet will enable us to optimize the image collection methods for each clinical trial. The AG Mednet solution is a perfect complement to our DICOM ArmorCar® and sFTP image collection tools. In an era of immense cost pressures, we are proud to be the only imaging core lab able to offer rapid and high-quality imaging data through customization of electronic image transfer, while also providing measurable time and cost savings," Wes Chapman, CEO of M2S stated.

Abraham Gutman, President & CEO of AG Mednet added: "We are delighted to be working with M2S. The AG Mednet network platform with its simple to use web-enabled front-end functionality will reduce significantly the number of site queries, while providing M2S with a highly scalable solution to fit the needs of the most demanding global trials."

M2S has been utilizing web-based methods for rapid and secure electronic image collection and transfer since 2002, with their proprietary network transfer device, the DICOM Armor Car (DAC®), which has an installed base of 287 sites worldwide. The AG Mednet network, in use at over 600 investigator sites globally, provides a web-enabled "front-end," allowing sites to de-identify exams, fill electronic transmittal forms and submit the data directly to M2S trial repositories. Whether a trial is a Phase I using imaging for inclusion criteria, or a Phase III multi-center international study with multiple imaging modalities for surrogate endpoints, M2S has the technology and process combination to provide the best customized solution.

About M2S, Inc.
M2S is a full-service imaging CRO, providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as patient registry databases. For the past 10 years, M2S has managed, under protocol, millions of images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com.

About AG Mednet, Inc.
AG Mednet, Inc. is a global diagnostic imaging network. Pharmaceutical, biotech and medical device companies, core labs and clinical research organizations utilizing imaging technology as part of their trial protocol rely on AG Mednet's automated system to enable the secure electronic transfer of cases from hundreds of locations, enhancing site compliance while providing detailed reporting necessary to meet the most stringent regulatory requirements. Additional information about AG Mednet is available at www.agmednet.com.

# # #

Read the full story at http://www.prweb.com/releases/clinical/tirals/prweb2217894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement
2. ULURU Inc. Announces Senior Management Change
3. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
4. National Western Life Announces 2008 Fourth Quarter and 2008 Earnings
5. Celebrity Chef Cat Cora Announces First Pregnancy
6. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
7. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
8. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
9. Victory Pharma Announces $45 Million Equity Financing
10. Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing
11. Pharmos Corporation Announces Receipt of Nasdaq Delisting Determination
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
(Date:2/17/2017)... ... February 17, 2017 , ... ... Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. ... distinguish between corrective action (CA) and preventive action (PA)? , The methods share ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... GA (PRWEB) , ... February 17, 2017 , ... Like ... to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), ... been a key focus area for hospitals across the nation. While many providers are ...
(Date:2/16/2017)... York, New York (PRWEB) , ... February 17, ... ... work and determination. After what took over 10 years of research, development and ... technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ingredients ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection ... patient care, NWH has achieved Magnet® recognition for the second time, ... 2017. The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
(Date:2/16/2017)... Ontario , Feb. 16, 2017  Aralez Pharmaceuticals ... global specialty pharmaceutical company, today announced that executive management ... Conference to be held February 22-23, 2017. Adrian ... of the Company at 1:35 p.m. local time on ... and audio archive for the event may be accessed ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
Breaking Medicine Technology: